Zenas BioPharma: Ownership Change Reported
Ticker: ZBIO · Form: 4 · Filed: Apr 29, 2026 · CIK: 0001953926
| Field | Detail |
|---|---|
| Company | Zenas Biopharma, Inc. (ZBIO) |
| Form Type | 4 |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Zenas BioPharma insider Leon O. Moulder Jr. filed a Form 4 on 4/28/26, reporting ownership changes.
AI Summary
On April 28, 2026, Leon O. Moulder Jr. reported a change in beneficial ownership of securities for Zenas BioPharma, Inc. The filing is a Form 4, indicating a statement of changes in beneficial ownership.
Why It Matters
Form 4 filings are crucial for investors as they disclose changes in stock ownership by company insiders, which can signal their confidence or concerns about the company's future.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of ownership changes by an insider and does not inherently indicate new risks for the company.
Key Players & Entities
- Leon O. Moulder Jr. (person) — Reporting person for ownership change
- Zenas BioPharma, Inc. (company) — Issuer of securities
- Form 4 (document) — Type of SEC filing
FAQ
What type of SEC filing is this?
This is a Form 4 filing, which is a Statement of changes in beneficial ownership of securities.
Who is the reporting person?
The reporting person is Leon O. Moulder Jr.
What is the name of the company involved?
The company involved is Zenas BioPharma, Inc.
What is the date of the report?
The period of report is 2026-04-28.
What is the accession number for this filing?
The SEC Accession No. is 0001104659-26-051889.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 29, 2026 by Leon O. Moulder Jr. regarding Zenas BioPharma, Inc. (ZBIO). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.